Idylla System

| September 12, 2017

Idylla™

 

 

 

 

 

 

Idylla™ Product Features

 

Idylla™, Biocartis’ fully automated, real-time PCR based molecular diagnostics system, is designed to offer fast and easy access to clinical molecular diagnostic information, anywhere and anytime. Idylla™ covers the entire process from sample to result in a time frame of 35 to 150 minutes with less than 2 minutes hands-on time. Idylla™ is applicable for a wide range of clinical sample types and can analyze both RNA and DNA. The fully integrated system enables clinical laboratories to perform a broad range of applications in oncology, infectious diseases and beyond.

Idylla™ and the system’s first assay, the Idylla™ BRAF Mutation Test, have obtained CE-IVD marking.

EASE-OF-USE

• Fully automated sample-to-result process
• Walk-away system (no need for any intervention during the automatic process)
• All reagents integrated in a single cartridge
• Only 1 manual step
• Storage and shipment at room temperature

FAST RESULTS

• Less than 2 minutes hands-on time
• Short turnaround time – 40 to 150 minutes

ACCURATE RESULTS

• High sensitivity
• Highly standardized technology
• Contamination-controlled design

SAMPLE VERSATILITY

• For solid and liquid biopsy ( Cancer Circulating Tumor cell / plasma)

MULTIPLEXING CAPABILITY

• Detection of up to 52 relevant mutations in one cartridge
• Multiple genes and loci detection in one cartridge

ACCESSIBLE

• Access on demand – no need for pre-processing or batching

CONNECTIVITY

• Remote assistance, monitoring and upgrading
• Bi-directional LIS

Diagnostic products (CE IVD)

– Idylla™ BRAF Mutation Test
– Idylla™ KRAS Mutation Test
– Idylla™ NRAS-BRAF Mutation Test
– Idylla™ NRAS Mutation Test
– Idylla™ EGFR Mutation Test

Research products (RUO)

– Idylla™ BRAF Mutation Assay
– Idylla™ KRAS Mutation Assay
– Idylla™ EGFR Mutation Assay
– Idylla™ NRAS-BRAF-EGFR S492R Mutation Assay

Plasma and Circulating Tumor Cell Sample

Research products (RUO)

– Idylla™ ctBRAF Mutation Assay
– Idylla™ ctKRAS Mutation Assay
– Idylla™ ctNRAS-BRAF-EGFR S492R

 

Future oncology assay targets


 FFPE Sample Diagnostics Product

– Idylla™  MSI

Plasma and Circulating Tumor Cell Sample

–  Idylla™ ctNRAS-BRAF
–  Idylla™ ctEGFR

 


To preserve your sample and keep your sample integrity, please find our next product..

Tags: , , , , , , , ,

Category: Molecular Oncology, Molecular Oncology Platform

Comments are closed.